Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

Aerobic exercise significantly lowers Alzheimer’s disease markers and improves brain health, offering a promising preventive ...

Welcome to your Cure magazine hub - your destination for the latest news from across Alzheimer’s Research UK. We exist for a cure. Thank you for standing with us. You are helping our scientists ...

Alzheimer’s disease is currently the third-leading cause of death among seniors in the U.S., following cardiovascular disease ...

Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...

But the 72-year-old Mendoza, who has not been diagnosed with Alzheimer’s, isn’t getting the exam at a doctor’s office or a clinical lab. She’s in a comfortable and familiar place, sipping Cuban coffee ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...